Dismantling Racism Against Black,Indigenous,and People of Color across the Substance use Continuum: A Position Statement of the Association for Multidisciplinary Education and Research in Substance use and Addiction
Restricted accessArticle commentaryFirst published online January, 2021
Dismantling Racism Against Black,Indigenous,and People of Color across the Substance use Continuum: A Position Statement of the Association for Multidisciplinary Education and Research in Substance use and Addiction
The Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) acknowledges that racism profoundly affects persons who use alcohol and other drugs. Racism's deadly effects compounded with other social determinants of health result in a cascade of negative impacts. The AMERSA Board of Directors (BOD) proposes an initial set of strategies to promote diversity, equity, and inclusion using a framework that speaks to four key AMERSA experiences: engagement, education, mentorship, and leadership. Through these strategies, AMERSA commits to promoting equity and inclusion to dismantle the individual, institutional, and structural racism that has permeated the United States for centuries. Abstracts of paper and poster presentations are also provided (Supplemental Material).
BaileyZD, KriegerN, AgénorM, GravesJ, LinosN, BassettMT.Structural racism and health inequities in the USA: evidence and interventions. The Lancet. 2017;389(10077):1453–1463.
5.
ShokouhSMH, MohammadARAB, EmamgholipourS, RashidianA, MontazeriA, ZaboliR.Conceptual models of social determinants of health: a narrative review. Iranian Journal of Public Health. 2017;46(4):435.
Substance Abuse and Mental Health Services Administration (SAMHSA). The Opioid Crisis and the Black/African American Population: An Urgent Issue. Publication No. PEP20-05-02-001. Rockville, MD: Office of Behavioral Health Equity, Substance Abuse and Mental Health Services Administration; 2020.
8.
Bryant‐DavisT, AdamsT, AlejandreA, GrayAA.The trauma lens of police violence against racial and ethnic minorities. Journal of Social Issues. 2017;73(4):852–871.
9.
SohnH.Racial and ethnic disparities in health insurance coverage: dynamics of gaining and losing coverage over the life-course. Popul Res Policy Rev. 2017;36(2):181–201.
10.
LardierDT.Jr, Substance use among urban youth of color: Exploring the role of community-based predictors, ethnic identity, and intrapersonal psychological empowerment. Cultur Divers Ethnic Minor Psychol. 2019;25(1):91–103.
11.
ProG, CamplainR, SaboS, BaldwinJ, GilbertPA.Substance abuse treatment in correctional versus non-correctional settings: analysis of racial/ethnic and gender differences. J Health Disp Res Pract. 2018;12(3):1.
12.
TrentM, DooleyDG, DougéJ, Section on Adolescent Health.The impact of racism on child and adolescent health. Pediatrics. 2019;144(2):e20191765.
13.
BravemanP.Health disparities and health equity: concepts and measurement. Annu Rev Public Health. 2006;27:167–194.
14.
NetherlandJ, HansenHB.The war on drugs that wasn't: wasted whiteness, “Dirty Doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664–686.
15.
GersteinDR, HarwoodHJ.. Treating Drug Problems: Commissioned Papers on Historical, Institutional, and Economic Contexts of Drug Treatment: Volume 2. Washington, DC: National Academy Press; 1992.
16.
WhiteKM, HolmanMR.Marijuana prohibition in California: racial prejudice and selective-arrests. Race, Gender & Class. 2012;19(3/4):75–92.
17.
DollarCB.Criminalization and drug “wars” or medicalization and health “epidemics”: How race, class, and neoliberal politics influence drug laws. Crit Crim. 2019;27(2):305–327.
18.
SolomonR.Racism and its effect on cannabis research. Cannabis Cannabinoid Res. 2020;5(1):2–5.
FellnerJ.Race, drugs and law enforcement in the United States. Stanford Law and Policy Review. 2009;20(2):257–292.
26.
VaginsDJ, McCurdyJ.. Cracks in the System: Twenty Years of the Unjust Federal Crack Cocaine Law. Washington, DC: American Civil Liberties Union; 2006.
27.
AcevedoA, PanasL, GarnickD, . Disparities in the treatment of substance use disorders: does where you live matter?J Behav Health Serv Res. 2018;45(4):533–549.
28.
HarpKL, BuntingAM.The racialized nature of child welfare policies and the social control of Black bodies. Social Politics: International Studies in Gender, State & Society. 2020;27(2):258–281.
PaulDWJr, KnightKR, CampbellA, AronsonL.Beyond a moment—reckoning with our history and embracing antiracism in medicine. N Engl J Med. 2020;383(15):1404–1406.
31.
JacobsonJO, RobinsonPL, BluthenthalRN.Racial disparities in completion rates from publicly funded alcohol treatment: economic resources explain more than demographics and addiction severity. Health Serv Res. 2007;42(2):773–794.
32.
MancherM, LeshnerAI. eds. National Academies of Sciences, Engineering, and Medicine. Treatment with medications for opioid use disorder in different populations. In Medications for Opioid Use Disorder Save Lives. US: National Academies Press; 2019.
33.
KuninsHV. Structural racism and the opioid overdose epidemic: the need for antiracist public health practice. JPHMP. 2020;26(3):201–205.
34.
LópezN, GadsdenVL. Health inequities, social determinants, and intersectionality; 2016.
35.
MontgomeryL, BurlewAK, HaenyAM, JonesCA.A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network. Psychol Addict Behav. 2020;34(1):117–127.
36.
MennisJ, StahlerGJ, AbouElMagdS, BaronDA.How long does it take to complete outpatient substance use disorder treatment? Disparities among Blacks, Hispanics, and Whites in the US. Addict Behav. 2019;93:158–165.
37.
HawkM, CoulterRW, EganJE, . Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.
StergiopoulosV, GozdzikA, MisirV, . The effectiveness of a Housing First adaptation for ethnic minority groups: findings of a pragmatic randomized controlled trial. BMC Public Health. 2016;16(1):1110.
LandryLG, AliN, WilliamsDR, RehmHL, BonhamVL.Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff. 2018;37(5):780–785.
42.
ScharffDP, MathewsKJ, JacksonP, HoffsuemmerJ, MartinE, EdwardsD.More than Tuskegee: understanding mistrust about research participation. Journal of Health Care for the Poor and Underserved. 2010;21(3):879.
43.
GeorgeS, DuranN, NorrisK.A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104(2):e16–e31.
44.
Shogren M, Hagle H, Cook M, Mancini P, Heitkamp T & ATTC Network CLAS Standards Workgroup. Roadmap for Training and Technical Assistance Efforts in Substance Use Service Administration. Grand Forks, North Dakota: ATTC Network Coordinating Office; 2019.
45.
HurtadoS, CabreraNL, LinMH, ArellanoL, EspinosaLL.Diversifying science: underrepresented student experiences in structured research programs. Res High Educ. 2009;50(2):189–214.
LettLA, OrjiWU, SebroR.Declining racial and ethnic representation in clinical academic medicine: a longitudinal study of 16 US medical specialties. PLOS One. 2018;13(11):e0207274.
48.
GrumbachK, MendozaR.Disparities in human resources: addressing the lack of diversity in the health professions. Health Aff. 2008;27(2):413–422.
49.
GrubbsV.Diversity, equity and inclusion that matter. N Engl J Med. 2020;383(4):e25.
HoppeTA, LitovitzA, WillisKA, . Topic choice contributes to the lower rate of NIH awards to African-American/black scientists. Sci Adv. 2019;5(10):eaaw7238.
MatsuzakaS, KnappM.Anti-racism and substance use treatment: addiction does not discriminate, but do we?J Ethn Subst Abuse. 2020;19(4):567–593.
54.
VyasDA, EisensteinLG, JonesDS. Hidden in plain sight—reconsidering the use of race correction in clinical algorithms. N Engl J Med.2020;383:874–882.
55.
Van BoekelLC, BrouwersEP, van WeeghelJ, GarretsenHF. Healthcare professionals’ regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend. 2014;134:92–98.
56.
BroylesLM, BinswangerIA, JenkinsJA, . Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217–221.
57.
KellyJF, SaitzR, WakemanS.Language, substance use disorders, and policy: the need to reach consensus on an “addiction-ary. Alcohol Treat Quart. 2016;34(1):116–123.
58.
JamesK, JordanA.The opioid crisis in black communities. J Law Med Ethics. 2018;46(2):404–421.
59.
WangQQ, KaelberDC, XuR, VolkowND.COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020:1–10. doi: 10.1038/s41380-020-00880-7.
60.
JonesCP.Toward the science and practice of anti-racism: launching a National Campaign against Racism. Ethn Dis. 2018;28(Suppl 1):231–234.
61.
RüschN, AngermeyerMC, CorriganPW.Mental illness stigma: concepts, consequences, and initiatives to reduce stigma. Eur Psychiatry. 2005;20(8):529–539.
62.
GullifordM.Discrimination and public health. Lancet Public Health. 2019;4(4):e173–e174.
63.
FreireP.1970. Pedagogy of the Oppressed. USA: Bloomsbury publishing.
64.
KohanWO.Paulo Freire and the value of equality in education. Educ Pesqui. 2019;45:1–18.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
